Company Shares of PerkinElmer (NYSE:PKI) Rally 2.45%

PerkinElmer (NYSE:PKI) has been under a strong bear grip, hence the stock is down -1.11% when compared to the S&P 500 in the past 4 weeks. However, in the near-term, buying emerged at lower levels and the stock has outperformed the S&P 500 by 1.15% in the past 1 week. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 2.45% in the last 1 week, and is up 0.48% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.

The company shares have rallied 3.69% from its 1 Year high price. On May 26, 2016, the shares registered one year high at $56.12 and the one year low was seen on Feb 5, 2016. The 50-Day Moving Average price is $53.48 and the 200 Day Moving Average price is recorded at $50.49.

The stock has recorded a 20-day Moving Average of 2.49% and the 50-Day Moving Average is 1.22%.


PerkinElmer (NYSE:PKI): stock turned positive on Friday. Though the stock opened at $53.02, the bulls momentum made the stock top out at $54.04 level for the day. The stock recorded a low of $53.01 and closed the trading day at $53.95, in the green by 2.59%. The total traded volume for the day was 653,837. The stock had closed at $52.59 in the previous days trading.

In an insider trading activity,The director of Perkinelmer Inc, Michas Alexis P sold 1,953 shares at $54.85 on June 2, 2016. The Insider selling transaction had a total value worth of $107,122. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.

PerkinElmer, Inc. is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates its business in two segments: Human Health and Environmental Health. The Companys Human Health segment concentrates on developing diagnostics, tools and applications to help detect diseases earlier and more accurately, and to accelerate the discovery and development of new therapies. The Companys Environmental Health segment provides products, services and solutions to facilitate the creation of safer food and consumer products, more secure surroundings and efficient energy resources. The Company markets its products and services in more than 150 countries.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.